Reneo Pharmaceuticals (RPHM) Q2 2024 Earnings

7MayConfirmed
Q4 2022
Q2 2023
Q3 2023
Q2 2024
-0.65
-0.52
-0.38
-0.25

Details

Expected EPS
-0.436667
Actual EPS
-0.25
Surprise EPS
0.19
Surprise Percent
+42.75%

Description

Reneo Pharmaceuticals (RPHM) has reported earnings of -0.25 per share for Q2 2024.

0 Comments

Share your thoughts